RE:RE:Biotech M&A to Boom across a landscape of uncharted markets Big pharma’s focus for future acquisitions
When considering the next wave of potential acquisitions, it’s clear that big pharma is actively seeking opportunities in various areas of interest. One particularly promising field is oncology, where significant potential for further advancements exists. The expanding knowledge surrounding the immune system is also a driving force behind increased activity in this sector.
While some early-stage companies that went public in recent years may have encountered setbacks, many of them continue to progress their programs ..[that] creates the potential for future inflection points on the horizon that could attract further interest from investors and industry players.
“If the markets start to behave more fundamentally,” says Renza, “good data will be rewarded.
We're in a fortunate position where larger global players are well organized around key therapeutic areas and innovations, so when science and value are proven, they're ready deploy their resources and help to potentiate that opportunity.